3D Tissue Models

Paul G Polakis

TypeWhite Paper Summary

Developing alliances has been one of Genentech's key strategies for success from its inception. Several marketed products and products in clinical development have arisen from successful collaborations. Genentech considers collaborations wherever there is excellent science and the potential for a good strategic fit. Genentech is dedicated to bringing considerable resources to the alliance, and is open to different collaboration structures. Genentech has the resources of a large company, including world-class research, clinical, and sales and marketing expertise, but has retained the energy and drive of a small, growing company.

Name:Paul G. Polakis

Previous Comments

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.